Sepsis drug developer Matisse Pharmaceuticals raises €14 million Series A
Matisse Pharmaceuticals Issuer · Brightlands Venture Partners Investor · LIOF Investor
Intelligence
The deal
- Type
- Funding
- Amount
- €14M
- Status
- Closed
- Round
- Series A
- Valuation
- Not recorded
- Region
- Netherlands
- Date
- 17 September 2026
As of this development: a later development may record new terms.
Lifecycle
- Announced
- Closed
The parties
Activity